{"id":11135,"date":"2022-12-01T09:14:06","date_gmt":"2022-12-01T09:14:06","guid":{"rendered":"https:\/\/marylanddailygazette.com\/global-equols-market-size-and-market-scenario-2022-by-manufacturers-competitive-landscape-price-sales-revenue-market-share-latest-development-plan-and-forecast-to-2028\/"},"modified":"2022-12-01T09:14:06","modified_gmt":"2022-12-01T09:14:06","slug":"global-equols-market-size-and-market-scenario-2022-by-manufacturers-competitive-landscape-price-sales-revenue-market-share-latest-development-plan-and-forecast-to-2028","status":"publish","type":"post","link":"https:\/\/marylanddailygazette.com\/global-equols-market-size-and-market-scenario-2022-by-manufacturers-competitive-landscape-price-sales-revenue-market-share-latest-development-plan-and-forecast-to-2028\/","title":{"rendered":"Global Equols Market Size and Market Scenario 2022 by Manufacturers Competitive Landscape, Price, Sales, Revenue Market Share, Latest Development Plan and Forecast to 2028"},"content":{"rendered":"

Global Equols Market Size and Market Scenario 2022 by Manufacturers Competitive Landscape, Price, Sales, Revenue Market Share, Latest Development Plan and Forecast to 2028<\/a><\/p>\n

The Equols market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa.\n<\/p>\n

\u201cFinal Report will add the analysis of the impact of COVID-19 on this industry.\u201d<\/p>\n

The Global \u201cEquols Market<\/a>\u201d research report give detailed expansion of the main growth drivers, market size estimates and forecasts. The report looks at current scenarios including market competitive situation, trends, market concentration rate market analysis by type, application, and manufacture and forecasted market growth to 2028. The report looks at sales revenue, secondary sources, and a detailed analysis of the company\u2019s market share in the respective markets. Major market participants to calculate market size.<\/p>\n

Get a Sample Copy of the Report at \u2013 <\/strong>https:\/\/www.industryresearch.co\/enquiry\/request-sample\/22036133<\/a><\/p>\n

Equols Market Analysis and Insights:<\/strong><\/p>\n

Equol ,a metabolite of soybeans, is an important isoflavone in humans\uff0cspecifically binds to 5\u03b1-DHT, has a modest affinity for recombinant estrogen receptor ER\u03b2. Equol is a metabolite produced from the soy phytoestrogen daidzein by the action of gut microflora. Equol has higher affinity for both ERs (estrogen receptors including ERalpha and ERbeta). Equol exists as the enantiomers R-equol and S-equol. S-equol has a high binding affinity, preferential for ERbeta with a Ki of 16 nM whereas R-equol binds more weakly and with a preference for ERalpha K with a Ki of 50 nM. Equol is superior to all other isoflavones in its antioxidant activity. Equol has antioestrogenic properties. Equol is a 100-fold more potent than daidzein in stimulating an oestrogenic response. Equol is also more effective than daidzein in competing with 3 H-oestradiol for binding to the ER. Equol stimulates the growth of MCF-7 cells in a concentration-dependent manner. Although equol exhibits oestrogenic activity, exposure of MCF-7 cells to equol simultaneously with oestradiol is effective in reducing pS2 mRNA expression. Equol results in the downregulation of ER mRNA expression.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Equols estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR during the forecast period 2022-2028.
The USA market for Equols is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR during the forecast period of 2023 through 2028.
The China market for Equols is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR during the forecast period of 2023 through 2028.
The Europe market for Equols is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR during the forecast period of 2023 through 2028.
The global key manufacturers of Equols include Tocris Bioscience, Cayman Chemical, Selleck Chemicals, Merck, Santa Cruz Biotechnology, Inc., Dr Tobias and Otsuka, etc. In 2021, the global top five players had a share approximately in terms of revenue.<\/p>\n

Get a Sample Copy of the Equols Market Report 2022<\/a><\/p>\n

Report Scope<\/strong><\/p>\n

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers\u2019 production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Equols manufacturers, distributors, end users, industry associations, governments\u2019 industry bureaus, industry publications, industry experts, third party database, and our in-house databases.<\/p>\n

Key Companies Covered<\/strong><\/p>\n

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022.<\/p>\n

Some of the players in the research report include:<\/strong><\/p>\n